Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.770
-0.070 (-3.80%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Coherus Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 273 | 172 | 159 | 371 | 778 | 1,225 | |
| Market Cap Growth | 217.40% | 7.95% | -57.13% | -52.31% | -36.55% | -2.13% | |
| Enterprise Value | 155 | 34 | 361 | 718 | 971 | 1,176 | |
| Last Close Price | 1.77 | 1.42 | 1.38 | 3.33 | 7.92 | 15.96 | |
| PE Ratio | 1.23 | 1.02 | 5.58 | - | - | - | |
| PS Ratio | 6.47 | 4.07 | 6.03 | 1.44 | 3.68 | 3.75 | |
| PB Ratio | 3.51 | 2.81 | -1.20 | -1.92 | -5.66 | 12.54 | |
| P/TBV Ratio | 18.47 | 11.62 | - | - | - | 13.02 | |
| EV/Sales Ratio | 3.68 | 0.81 | 13.67 | 2.79 | 4.60 | 3.60 | |
| Debt / Equity Ratio | 0.89 | 0.89 | -2.26 | -2.49 | -3.50 | 4.29 | |
| Net Debt / Equity Ratio | -1.93 | -1.93 | -1.31 | -1.88 | -2.10 | 0.02 | |
| Net Debt / EBITDA Ratio | 0.68 | 0.68 | -0.94 | -1.92 | -1.14 | -0.01 | |
| Net Debt / FCF Ratio | 0.85 | 0.85 | -8.45 | -2.08 | -1.20 | -0.05 | |
| Asset Turnover | 0.12 | 0.12 | 0.05 | 0.46 | 0.36 | 0.43 | |
| Inventory Turnover | 3.74 | 3.74 | 0.26 | 3.14 | 1.83 | 1.41 | |
| Quick Ratio | 1.36 | 1.36 | 0.88 | 1.14 | 2.17 | 3.27 | |
| Current Ratio | 1.47 | 1.47 | 1.21 | 1.43 | 2.75 | 3.64 | |
| Return on Equity (ROE) | - | - | - | - | - | -151.62% | |
| Return on Assets (ROA) | -31.20% | -31.20% | -21.92% | -21.75% | -27.68% | -21.68% | |
| Return on Invested Capital (ROIC) | - | - | -179.76% | -120.38% | -204.79% | -205.76% | |
| Return on Capital Employed (ROCE) | -149.60% | -149.60% | -114.20% | -64.90% | -75.10% | -51.30% | |
| Earnings Yield | 61.56% | 97.89% | 17.93% | -64.15% | -37.52% | -23.43% | |
| FCF Yield | -50.74% | -80.70% | -12.86% | -47.16% | -31.01% | -3.16% | |
| Buyback Yield / Dilution | -2.26% | -2.26% | -21.65% | -21.30% | -2.89% | 9.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.